Your browser doesn't support javascript.
loading
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease.
Bushnell, Justin; Hammers, Dustin B; Aisen, Paul; Dage, Jeffrey L; Eloyan, Ani; Foroud, Tatiana; Grinberg, Lea T; Iaccarino, Leonardo; Jack, Clifford R; Kirby, Kala; Kramer, Joel; Koeppe, Robert; Kukull, Walter A; La Joie, Renaud; Mundada, Nidhi S; Murray, Melissa E; Nudelman, Kelly; Rumbaugh, Malia; Soleimani-Meigooni, David N; Toga, Arthur; Touroutoglou, Alexandra; Vemuri, Prashanthi; Atri, Alireza; Day, Gregory S; Duara, Ranjan; Graff-Radford, Neill R; Honig, Lawrence S; Jones, David T; Masdeu, Joseph; Mendez, Mario; Musiek, Erik; Onyike, Chiadi U; Riddle, Meghan; Rogalski, Emily; Salloway, Steven; Sha, Sharon; Turner, Raymond S; Wingo, Thomas S; Wolk, David A; Carrillo, Maria C; Dickerson, Bradford C; Rabinovici, Gil D; Apostolova, Liana G; Clark, David G.
Afiliación
  • Bushnell J; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Hammers DB; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Aisen P; Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.
  • Dage JL; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Eloyan A; Department of Biostatistics, Center for Statistical Sciences, Brown University, Providence, Rhode Island, USA.
  • Foroud T; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Grinberg LT; Department of Pathology, University of California - San Francisco, San Francisco, California, USA.
  • Iaccarino L; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Jack CR; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Kirby K; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kramer J; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Koeppe R; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Kukull WA; Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
  • La Joie R; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Mundada NS; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Murray ME; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Nudelman K; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Rumbaugh M; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Soleimani-Meigooni DN; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Toga A; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Touroutoglou A; Laboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, Los Angeles, California, USA.
  • Vemuri P; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Atri A; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Day GS; Banner Sun Health Research Institute, Sun City, Arizona, USA.
  • Duara R; Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
  • Graff-Radford NR; Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami, Florida, USA.
  • Honig LS; Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
  • Jones DT; Taub Institute and Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA.
  • Masdeu J; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Mendez M; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Musiek E; Nantz National Alzheimer Center, Houston Methodist and Weill Cornell Medicine, Houston, Texas, USA.
  • Onyike CU; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Riddle M; Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Rogalski E; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Salloway S; Department of Neurology, Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Sha S; Department of Psychiatry and Behavioral Sciences, Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Turner RS; Department of Neurology, Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Wingo TS; Department of Neurology & Neurological Sciences, Stanford University, Palo Alto, California, USA.
  • Wolk DA; Department of Neurology, Georgetown University, Washington D.C., USA.
  • Carrillo MC; Department of Neurology and Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Dickerson BC; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Rabinovici GD; Medical & Scientific Relations Division, Alzheimer's Association, Chicago, Illinois, USA.
  • Apostolova LG; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Clark DG; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
Alzheimers Dement ; 19 Suppl 9: S29-S41, 2023 11.
Article en En | MEDLINE | ID: mdl-37653686
ABSTRACT

INTRODUCTION:

The Rey Auditory Verbal Learning Test (RAVLT) is a useful neuropsychological test for describing episodic memory impairment in dementia. However, there is limited research on its utility in early-onset Alzheimer's disease (EOAD). We assess the influence of amyloid and diagnostic syndrome on several memory scores in EOAD.

METHODS:

We transcribed RAVLT recordings from 303 subjects in the Longitudinal Early-Onset Alzheimer's Disease Study. Subjects were grouped by amyloid status and syndrome. Primacy, recency, J-curve, duration, stopping time, and speed score were calculated and entered into linear mixed effects models as dependent variables.

RESULTS:

Compared with amyloid negative subjects, positive subjects exhibited effects on raw score, primacy, recency, and stopping time. Inter-syndromic differences were noted with raw score, primacy, recency, J-curve, and stopping time.

DISCUSSION:

RAVLT measures are sensitive to the effects of amyloid and syndrome in EOAD. Future work is needed to quantify the predictive value of these scores. HIGHLIGHTS RAVLT patterns characterize various presentations of EOAD and EOnonAD Amyloid impacts raw score, primacy, recency, and stopping time Timing-based scores add value over traditional count-based scores.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Memoria Episódica Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Memoria Episódica Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...